These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24279860)

  • 21. Susceptibility genes for the side effect of antipsychotics on body weight and obesity.
    Chagnon YC
    Curr Drug Targets; 2006 Dec; 7(12):1681-95. PubMed ID: 17168843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.
    Shing EC; Tiwari AK; Brandl EJ; Zai CC; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Neuropsychobiology; 2014; 69(1):59-63. PubMed ID: 24481458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity.
    Hill MJ; Reynolds GP
    Brain Res; 2007 May; 1149():14-7. PubMed ID: 17376412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.
    Gregoor JG; Mulder H; Cohen D; van Megen HJ; Egberts TC; Heerdink ER; van der Weide J
    J Clin Psychopharmacol; 2010 Dec; 30(6):702-5. PubMed ID: 21105285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.
    Perez-Iglesias R; Mata I; Amado JA; Berja A; Garcia-Unzueta MT; Martínez García O; Arranz MJ; Vazquez-Barquero JL; Crespo-Facorro B
    J Clin Psychopharmacol; 2010 Dec; 30(6):661-6. PubMed ID: 21105276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
    Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
    J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.
    De Luca V; Mueller DJ; de Bartolomeis A; Kennedy JL
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):697-704. PubMed ID: 17291373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacogenetics of antipsychotic-induced adverse events.
    Müller DJ; Chowdhury NI; Zai CC
    Curr Opin Psychiatry; 2013 Mar; 26(2):144-50. PubMed ID: 23370274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
    Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
    Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Egberts AC; Scheffer H
    Pharmacogenomics J; 2007 Oct; 7(5):318-24. PubMed ID: 17016522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
    Malhotra AK; Correll CU; Chowdhury NI; Müller DJ; Gregersen PK; Lee AT; Tiwari AK; Kane JM; Fleischhacker WW; Kahn RS; Ophoff RA; Meltzer HY; Lencz T; Kennedy JL
    Arch Gen Psychiatry; 2012 Sep; 69(9):904-12. PubMed ID: 22566560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
    Thompson A; Lavedan C; Volpi S
    Psychiatry Res; 2010 Feb; 175(3):271-3. PubMed ID: 20045196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
    De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
    Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.
    Luo C; Liu J; Wang X; Mao X; Zhou H; Liu Z
    Neurosci Bull; 2019 Jun; 35(3):561-580. PubMed ID: 30607769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of the central control of weight regulation and the effect of antipsychotic medication.
    Tighe S; Dinan T
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):36-46. PubMed ID: 16280336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
    Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
    Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of antipsychotic treatment emergent weight gain in schizophrenia.
    Müller DJ; Kennedy JL
    Pharmacogenomics; 2006 Sep; 7(6):863-87. PubMed ID: 16981847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.
    Chowdhury NI; Tiwari AK; Souza RP; Zai CC; Shaikh SA; Chen S; Liu F; Lieberman JA; Meltzer HY; Malhotra AK; Kennedy JL; Müller DJ
    Pharmacogenomics J; 2013 Jun; 13(3):272-9. PubMed ID: 22310352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.